The Journal of Clinical Psychiatry

Page 402

More JCP Articles

Article

Antipsychotic Safety and Efficacy Concerns

December 14, 2007

Jonathan M. Meyer

Original Research

Are Depressed Outpatients With and Without a Family History of Substance Use Disorder Different? A Baseline Analysis of the STAR*D Cohort

December 14, 2007

Maurizio Fava, Madhukar H. Trivedi, Richard C. Shelton, et al

Letter to the Editor

A Case of Olanzapine-Induced Gestational Diabetes Mellitus in the Absence of Weight Gain

December 14, 2007

Mytilee P. Vemuri, Natalie L. Rasgon

Article

Cognitive Deficits in Patients With Schizophrenia: Effects and Treatment

December 14, 2007

Richard S. E. Keefe

Original Research

Comparative Assessment of the Incidence and Severity of Tardive Dyskinesia in Patients Receiving Aripiprazole or Haloperidol for the Treatment of Schizophrenia: A Post Hoc Analysis

December 14, 2007

James M. Eudicone, Andrei Pikalov, Del D. Miller, et al

Original Research

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

December 14, 2007

Michael E. Thase, George I. Papakostas, Stuart A. Montgomery, et al

Original Research

A Comparison of Initial Duloxetine Dosing Strategies in Patients With Major Depressive Disorder

December 14, 2007

David L. Dunner, Susan G. Kornstein, John H. Greist, et al

Original Research

Comparison of Intramuscular Ziprasidone, Olanzapine, or Aripiprazole for Agitation: A Quantitative Review of Efficacy and Safety

December 14, 2007

Leslie Citrome

ASCP Corner

What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 1: First-Line Treatments

December 14, 2007

Joseph F. Goldberg

Letter to the Editor

Corpus Callosum Dysplasia in Adult Attention-Deficit/Hyperactivity Disorder: A Case Report

December 14, 2007

Alexandra Philipsen, Ludger Tebartz van Elst, Evgeniy Perlov, et al

Article

The Costs of Schizophrenia.

December 14, 2007

Joseph P. McEvoy

Commentary

Diagnosing and Managing Complicated ADHD

December 14, 2007

Robert L. Findling, Laurence L. Greenhill, Christopher J. Kratochvil, et al

« 1 … 400 401 402 403 404 … 778 »

Antipsychotic Safety and Efficacy Concerns

Are Depressed Outpatients With and Without a Family History of Substance Use Disorder Different? A Baseline Analysis of the STAR*D Cohort

A Case of Olanzapine-Induced Gestational Diabetes Mellitus in the Absence of Weight Gain

Cognitive Deficits in Patients With Schizophrenia: Effects and Treatment

Comparative Assessment of the Incidence and Severity of Tardive Dyskinesia in Patients Receiving Aripiprazole or Haloperidol for the Treatment of Schizophrenia: A Post Hoc Analysis

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

A Comparison of Initial Duloxetine Dosing Strategies in Patients With Major Depressive Disorder

Comparison of Intramuscular Ziprasidone, Olanzapine, or Aripiprazole for Agitation: A Quantitative Review of Efficacy and Safety

What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 1: First-Line Treatments

Corpus Callosum Dysplasia in Adult Attention-Deficit/Hyperactivity Disorder: A Case Report

The Costs of Schizophrenia.

Diagnosing and Managing Complicated ADHD

ELSEWHERE:

FOLLOW US:

More JCP Articles

Antipsychotic Safety and Efficacy Concerns

Are Depressed Outpatients With and Without a Family History of Substance Use Disorder Different? A Baseline Analysis of the STAR*D Cohort

A Case of Olanzapine-Induced Gestational Diabetes Mellitus in the Absence of Weight Gain

Cognitive Deficits in Patients With Schizophrenia: Effects and Treatment

Comparative Assessment of the Incidence and Severity of Tardive Dyskinesia in Patients Receiving Aripiprazole or Haloperidol for the Treatment of Schizophrenia: A Post Hoc Analysis

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

A Comparison of Initial Duloxetine Dosing Strategies in Patients With Major Depressive Disorder

Comparison of Intramuscular Ziprasidone, Olanzapine, or Aripiprazole for Agitation: A Quantitative Review of Efficacy and Safety

What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 1: First-Line Treatments

Corpus Callosum Dysplasia in Adult Attention-Deficit/Hyperactivity Disorder: A Case Report

The Costs of Schizophrenia.

Diagnosing and Managing Complicated ADHD

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles